|
1 Indications And Usage Bupropion Hydrochloride Extended-Release Tablets (Xl) Are Indicated For The Treatment Of Major Depressive Disorder (Mdd), As Defined By The Diagnostic And Statistical Manual (Dsm). The Efficacy Of The Immediate-Release Formulation Of Bupropion Was Established In Two 4-Week Controlled Inpatient Trials And One 6-Week Controlled Outpatient Trial Of Adult Patients With Mdd. The Efficacy Of The Sustained-Release Formulation Of Bupropion In The Maintenance Treatment Of Mdd Was Established In A Long-Term (Up To 44 Weeks), Placebo-Controlled Trial In Patients Who Had Responded To Bupropion In An 8-Week Study Of Acute Treatment [See Clinical Studies ( 14 )] . The Physician Who Elects To Use Bupropion Hydrochloride Extended-Release Tablets (Xl) For Extended Periods Should Periodically Reevaluate The Long-Term Usefulness Of The Drug For The Individual Patient. Bupropion Hydrochloride Extended-Release Tablets (Xl) Are An Aminoketone Antidepressant Indicated For The Treatment Of Major Depressive Disorder (Mdd) ( 1 ). The Efficacy Was Established In Two 4-Week Trials, One 6-Week Trial With Bupropion Immediate-Release Formulation, And One Maintenance Trial With Bupropion Sustained-Release Formulation, All In Adults ( 14 ). Periodically Re-Evaluate Long-Term Usefulness For The Individual Patient ( 1 ).
|